Perfil
Charan Behl has been Head-Technical Affairs of Elite Pharmaceuticals, Inc. since February 2007 and served as Executive Vice President and Chief Scientific Officer from March 2006 to February 2007.
He served as Vice President-Research and Development of Nastech Pharmaceutical Corporation, Inc. from January 1995 to July 1998 and Executive Vice President-Research and Development from July 1988 to January 2001 and Research Leader of Hoffman La Roche from April 1981 to November 1994.
Dr. Behl served as Assistant Research Scientist at the University of Michigan from 1978 to 1981 and Chairman of Nasal Drug Delivery Focus Group, which was formed in 1995 from 1995 to 2001.
Dr. Behl received a BS in Pharmaceutical Sciences from BITS-Pilani, an MS in Pharmaceutics from Duquesne University and a PhD in Pharmaceutical Sciences from the University of Michigan.
Antiguos cargos conocidos de Charan Behl.
Empresas | Cargo | Fin |
---|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Director Técnico/Científico/I+D | 01/01/2001 |
University of Michigan | Corporate Officer/Principal | 01/01/1981 |
Formación de Charan Behl.
Duquesne University of The Holy Spirit | Graduate Degree |
University of Michigan | Doctorate Degree |
Birla Institute of Technology & Science | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Charan Behl